Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
C. Raymond Larkin
AddedMar 31, 2024
UpdatedMay 31, 2026
C. Raymond Larkin

C. Raymond Larkin

Board Member, Reva Medical

LinkedIn

C. Raymond Larkin's Career

Reva Medical
Reva Medical

San Diego, CA, US

Board Member· Board
NeuroPace
NeuroPace

Mountain View, CA, US

Board Member· Board
Align Techno
Align Techno

Tempe, AZ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

C. Raymond Larkin's Career

Reva Medical
Reva Medical
Public$146.6M751998San Diego, CA, US
Board Member· Board

Leadership at Reva Medical

Brian DoveyBrian DoveyBoard Member
Jeff AndersonJeff AndersonCEO
Tamara EliasTamara EliasBoard Member
Robert StockmanRobert StockmanBoard Member
Cheryl LiberatoreCheryl LiberatoreBoard Member
JAMES SCHIROJAMES SCHIROBoard Member
NeuroPace
NeuroPace
Public$307.3M1671997Mountain View, CA, US
Board Member· Board

Leadership at NeuroPace

Frank FischerFrank FischerBoard Member
Joel BeckerJoel BeckerBoard Member
Rakhi KumarRakhi KumarBoard Member
Sharon StevensonSharon StevensonBoard Member
David FischellDavid FischellFounder
Uri GeigerUri GeigerBoard Member

Similar to NeuroPace

NevroNevroRedwood City, CA, USMedical Devicesest. 2006NevroRedwood City, CA, US · est. 2006

Nevro Corp., a global medical device company, specializes in spinal cord stimulation systems to treat chronic pain.

Public · $555.8M1.1k
Epic NeuroEpic NeuroFountain Valley, CA, USMedical Devicesest. 2016Epic NeuroFountain Valley, CA, US · est. 2016

EPIC Neuro: Minimally invasive brain stimulation & EEG recording for stroke recovery.

Seed · $1M2
Cadence NeuroscienceCadence NeuroscienceRedmond, WA, USMedical Devicesest. 2017Cadence NeuroscienceRedmond, WA, US · est. 2017

Cadence Neuroscience: Innovating personalized brain stimulation therapies for neurological disorders.

Series B · $41M15
NeuroBionicsNeuroBionicsSeattle, WA, USMedical DevicesNeuroBionicsSeattle, WA, US

Developing medical devices for neurological disorders.

Series A · $6M6
Align Techno
Align Techno
Public$136M23.2k1997Tempe, AZ, US
Board Member· Board

Leadership at Align Techno

Sue SiegelSue SiegelBoard Member
Joe LacobJoe LacobBoard Member
Anne MyongAnne MyongBoard Member
Zia ChishtiZia ChishtiCo-Founder
Greg SantoraGreg SantoraBoard Member
Benjamin S. SchapiroBenjamin S. SchapiroBoard Member

C. Raymond Larkin's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to C. Raymond Larkin

Lance R. PickensLance R. PickensCo-Founder · MadeSolidEric TimkoEric TimkoBoard Member · NicoPat WadorsPat WadorsBoard Member · AccoladeSheryl ConleySheryl ConleyBoard Member · NeuroneticsWilliam LinkWilliam LinkBoard Member · Nexis VisionRyan HarrisRyan HarrisBoard Member · Target PharmaSolutions